SynapDx lures Kraft investment; Life Tech pours $18M into Dx plant;

 @FierceMedDev: CMO adds 200 medical device jobs in Ireland. Report | Follow @FierceMedDev

 @MarkHFierce: A new FMD feature--this week in FDA med tech violations, the device industry's police blotter. More | Follow @MarkHFierce

 @DamianFierce: Abbott won the FDA's OK for a diagnostic that detects birth defects and testicular cancer progress. News | Follow @DamianFierce

> SynapDx, developer of an autism blood test, has secured an undisclosed but "significant" investment from the Kraft Group, owner of the New England Patriots and other companies. Article

> Thermo Fisher ($TMO) has partnered with the University of Birmingham to develop mass spectrometry diagnostic technologies. More

> GE Healthcare ($GE) won FDA clearance for two new MR scanners the company says outperform and cost less than previous generations. Release

> March has been a rough month for dealmaking, as global M&A stumbled to its lowest rate in three years. Story

> Life Technologies ($LIFE) is investing $18 million to expand its molecular diagnostics facility in Pleasanton, CA. Item

> The FDA has applied its most serious label to Vascular Solutions' hemostasis valves, warning that a malfunction could lead to dangerous air embolisms in patients. Note

> Engineers at Caltech have teamed with Israel's LeukoDx to develop a portable device that can count white blood cells from anywhere, potentially helping patients with diseases like leukemia avoid repeat hospital visits. More

Biotech News

 @FierceBiotech: From FierceBiotechResearch.com: New drug could combat resistant #malaria strains. Story | Follow @FierceBiotech

@JohnCFierce: 3 yrs after its first CRL, AP Pharma gets another. Insists it can do a quick turnaround, but wrong again on FDA: News | Follow @JohnCFierce

@RyanMFierce: With big RNA deal, AstraZeneca's Soriot signals yen for risky science. More | Follow @RyanMFierce

> Connecticut pols stunned as Pfizer brings in the wrecking ball. Item

> Repros shares boom on promising PhIII results for testosterone drug. Report

> Biogen Idec rolls up FDA OK for blockbuster multiple sclerosis drug Tecfidera. News

Pharma News

@FiercePharma: Conquering the complexities of biologics to get to biosimilars. Special report | Follow @FiercePharma

@EricPFierce: Alexion files 8-K saying FDA is not impressed with its manufacturing at its Rhode Island plant. 8-K filing | Follow @EricPFierce

> Rose-colored glasses off for many of 2012's new drugs, report shows. More

> Drugstores push for access to secret PBM pricing-and-reimbursement info. Story

Vaccines News

> GSK vaccine plant helps U.S. arm for biodefense. Report

> Taboo topics: Sex, politics, religion... and vaccines? Article

> Swedish study adds to data linking GSK vax to narcolepsy. Item

> FDA moves decision day for GSK pandemic vaccine, but why? More

Pharma Manufacturing News

> Alexion gets warning letter for Soliris plant. Report

> FDA lifts ban on some Aurobindo antibiotics. News

> Injection point: BD, Teva, Hikma target sterile injectables. Story

> GSK gets OK for $91M vaccine plant with Texas A&M. Article

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.